FRONTEO,Inc. (2158)

Market cap
¥32B
P/E ratio
51.9x
FRONTEO provides AI-powered solutions for drug discovery, compliance, and legal investigations using its proprietary KIBIT technology to serve healthcare, corporate, and legal clients.
Period EndNet income margin (%) YoY (%)
Mar 31, 20259.1-123.61%
Mar 31, 2024-38.5+63.49%
Mar 31, 2023-23.6-296.97%
Mar 31, 202212+238.90%
Mar 31, 20213.5-140.49%
Mar 31, 2020-8.7-1674.87%
Mar 31, 20190.6-108.28%
Mar 31, 2018-6.7-20.38%
Mar 31, 2017-8.4+364.32%
Mar 31, 2016-1.8-143.33%
Mar 31, 20154.2-128.88%
Mar 31, 2014-14.5-239.84%
Mar 31, 201310.3-58.27%
Mar 31, 201224.8
AI Chat